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Abstract
Background: Ov-CHI-1 is a chitinase specifically expressed in the infective stage larvae of the
human filarial parasite Onchocerca volvulus. Evidence has show that it could be a vaccine candidate,
however, there is no data available regarding the immunological status of people naturally exposed
to infective stage larvae and thus provoked by this antigen.
Method: We analysed the Ov-CHI-1-specific immune response present in four endemic foci of
human onchocerciasis (Ecuador, Nigeria, Togo and Cameroon) by enzyme-linked immunosorbent
assays and T-cell proliferation assays.
Results: In these foci of infection, antibodies to Ov-CHI-1 were found to be present in only 22%
of individuals from Ecuador, but were detected in 42–62% of infected individuals in the three foci
from West Africa (Nigeria, Togo and Cameroon). There was found to be no relationship between
antibody level and age, gender, or infection intensity as indicated by microfilarial density and
numbers of skin nodules. The isotype response to Ov-CHI-1 was dominated by the presence of
IgG3, IgG1 was present to a lesser extent. Our results show a positive correlation between N- and
C-termini of Ov-CHI-1 in their ability to provoke humoral and cellular immune responses in the
human. Peripheral blood mononuclear cell (PBMC) proliferative responses to Ov-CHI-1 when
assayed, were found to be significantly higher in the individuals from endemic areas and there was
a statistically elevated response to Ov-CHI-1 in the infected individuals when compared to putative
immune individuals.
Conclusion: Ov-CHI-1 is an antigen that we have found strongly induces both humoral and
cellular immune responses in humans.
Introduction
Onchocerciasis is caused by infection with the parasitic
filarial nematode, Onchocerca volvulus. Typical pathology
of onchocerciasis are the symptoms of dermal atrophy
and blindness. The parasitic disease is present in 36 coun-
tries of Africa, the Arabian Peninsula and the Americas. 18
million people are infected and a further 120 million peo-
ple worldwide are at risk of infection [1]. Pathogenesis of
filarial disease is thought to be caused mainly by host in-
flammatory and immune responses to the parasite and to
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microfilarial and adult worm antigens [2–4]. Although a
recent study has related pathology present in the eye with
the presence of endosymbiotic Wolbachia  bacteria con-
tained within the onchocerca worm [5]. It is likely that
both the nematode and Wolbachia antigens are involved
in the disease pathogenesis.
Strategies to eliminate onchocerciasis have, in the past,
been based on vector control and / or mass treatment with
the microfilaricidal drug ivermectin [6]. A more efficient
control method has been suggested which would use drug
treatment combined with a prophylactic vaccine. There-
fore, it is important to characterise antigens playing criti-
cal roles in parasitic development and transmission
processes. Advances made by the filarial genome project
may be useful to this end. Protective immunity generated
against filarial parasites have been linked, in one study,
with the developmental stages of late L3 and L4 [7]. Irra-
diated L3 larvae have been found to induce protective im-
munity in rodent models of filarial disease [8–11], and
several recombinant L3 antigens have been proposed as
potential vaccine candidates [12,13]. The post-infective
stage and L3 to L4 moult are significant developmental
stages and the molecules expressed at this time may be of
special interest.
We have cloned and characterised a chitinase gene from
infective stage larvae of O. volvulus, Ov-CHI-1 [14,15]. Ov-
CHI-1 is a chitinase with several distinct features, namely,
stage-specificity, (only expressed within infective stage lar-
vae); organ specificity, (localised within the inclusion
bodies of the glandular oesophagus); being secreted dur-
ing late L3/L4 transition; and exhibiting high immuno-
genicity in experimental immunisation [14–16]. Recent
studies have highlighted the importance of this secreted,
stage-specific chitinase in experimental vaccinations to
filarial parasites. For example, Canlas et al., have shown
that the monoclonal antibody to Brugia malayi chitinase,
MF1, can cause the clearance of circulating B. malayi mi-
crofilaria (mf) in passive transfer experiments [17]. Im-
munization of Mongolian jirds with live attenuated
Samonella typhimurium expressing active A. viteae chitinase
resulted in a reduction in adult worm burden of 51.4%
[Lucis R, personal communication, 1999]. DNA vaccina-
tion with Ov-CHI-1 in our laboratory also resulted in a
53% reduction in parasite survival in a mouse chamber
model of onchocercasis [18]. Immunization of jirds with
recombinant B. malayi chitinase also induced partial pro-
tection against microfilaremia although it did not reduce
adult worm burden [19]. There is no data available how-
ever, on the immunological status of people naturally ex-
posed to, and provoked by, this antigen. Thus, we have
studied Ov-CHI-1-specific immune responses in several
endemic foci of human onchocerciasis. We believe that
data generated will increase knowledge of this molecule
and will aid further evaluation of the role of Ov-CHI-1 in
the pathogenesis of onchocerciasis.
Materials and Methods
Filarial material
Adult worms and microfilariae of O. volvulus were recov-
ered from nodules excised, after full informed consent
and ethical review, from patients attending a clinic at the
Medical Research Laboratories (MRL) in Kumba, Cam-
eroon (as part of a clinical management programme). Mi-
crofilariae were purified on discontinuous Percoll
gradients. Blackflies (Simulium damnosum s.l.) infected
with O. volvulus L3 larvae were obtained from the MRL,
Kumba, Cameroon. Cryopreserved infective larvae were
supplied by Dr Lustigman (New York Blood Centre, New
York, USA) on behalf of the Edna McConnell Clark Foun-
dation Onchocerciasis Resources Project (New York,
USA).
Expression of recombinant chitinase antigens
The details of expression and characterisation of recom-
binant Ov-CHI-1 have been described previously [14].
Briefly, all recombinant antigens used in this study were
expressed in BL21 E. coli using the expression vector
pJC40 [20]. The full-length protein consists of 497 amino
acids; the 5' protein encoded by the first 1107 bp cDNA
and the 3' protein consists of 138 amino acids which was
encoded by the 3' 528 bp cDNA. A His-tag sequence was
fused at the NH2 terminus to allow the recombinant anti-
gens to be purified by affinity chromatography on a Nick-
el column (Probond Resin, Invitrogen, Paisley, UK).
Human sera
Sera were obtained from the Edna McConnell Clark Foun-
dation (EMCF) onchocerciasis serum bank, maintained at
the Swiss Tropical Institute, Basel, Switzerland. Samples
from the EMCF serum bank originated from endemic re-
gions within Cameroon (n = 182), Togo (n = 67), Nigeria
(n = 39) and Ecuador (n = 55). In each of these locations,
sera were derived from individuals showing parasitologi-
cal signs of current infection (classified as 'infected'
[INF]), or from individuals that had neither palpable nod-
ules nor positive skin snips (classified as 'putatively im-
mune' [PI]). EMCF criteria for defining putative immunity
include a minimum of 20 years residency in the endemic
area and with no history of recent treatment (past 3 years).
Sera from unexposed individuals were obtained from vol-
unteers from the United Kingdom. For IgG subclass meas-
urement, 77 samples were selected based on total IgG
optical densities (ODs) over 0.44 OD, including 21 from
Ecuador (PI 13, INF 8), 37 from Cameroon (PI 18, INF
19) and 19 infected sera from Hohoe, Ghana (all INF).Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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Figure 1
ELISA analysis of the IgG response to recombinant Ov-CHI-1 in human onchocerciasis. Figure 1A, Comparison of the response 
in sera of endemic individuals from 4 endemic foci with uninfected controls from the United Kingdom. Mean values are indi-
cated by a horizontal line. Figure 1B, Comparison of the response in the sera of infected (INF) and putatively immune (PI) indi-
viduals from 4 endemic foci and from uninfected UK controls. Box and whisker plots illustrate the group mean values 
(horizontal bar), data points falling within the 25th to 75th percentile (boxed) and the range (vertical lines). * P = < 0.05 vs. UK 
controls † P = < 0.05 vs. Individuals from EucadorFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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Figure 2
IgG subclass analysis by ELISA on Ov-CHI-1 full-length antigen using 77 selected sera (see text). The whole profile of IgG1-IgG4 
responses is shown in Figure 2A. Figure 2B shows the relationship between microfilarial skin density and anti-Ov-CHI-1 IgG3 
level in these sera. The relationship of IgG1 with IgG3 is shown in Figure 2C.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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Enzyme-linked immunosorbent assays (ELISA)
Human sera were obtained as described above, and ana-
lysed by ELISA for IgG antibodies against O. volvulus L3
chitinase antigens. Briefly, Maxisorp plates (Nalge Nunc
International, USA) were coated overnight with purified
Ov-CHI-1 at a concentration of 1 µg/ml in 0.05 M carbon-
ate buffer (pH 9.6). Wells were blocked by overnight incu-
bation with 20% (v/v) soya milk in TST (Tris-Sodium
chloride-Tween buffer). Sera were diluted 1:200 in 20%
soya / TST and applied to duplicate plates for 2 hours at
room temperature. The wells were washed in TST, and
goat anti-human IgG (H+L) horseradish peroxidase con-
jugate (Nordic Immunological Laboratories, Tilburg, The
Netherlands) was added at 1:3000 dilution in 20% soya /
TST for 1 hour at room temperature. Plates were washed
and the assay was developed using 0.02% 2,2'-azinobis-
(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) (Sigma,
Dorset, UK). The absorbance at wavelength 405 nm was
read on a Dynastic MR 5000 plate reader.
IgG subclass ELISA
Isotype-specific antibodies were measured by using an
Ov-CHI-1 ELISA, employing isotype-specific conjugates.
Briefly, Maxisorp plates were coated overnight with puri-
fied Ov-CHI-1 at a concentration of 1 µg/ml in 0.05 M car-
bonate buffer (pH 9.6). Wells were blocked by overnight
incubation with 20% (v/v) soya milk in TST. Sera were di-
luted 1:200 in 20% soya / TST and applied to duplicate
plates for 2 hours at room temperature. The plates then
were probed with monoclonal antibodies to human IgG1
(1:200), IgG2 (1:100), IgG3 (1:200) and IgG4 (1:400)
(Nordic: Set MAU/IgG1-4, Nordic Immunological Labo-
ratories, Tilburg, The Netherlands) for 2 hours at room
temperature, washed and probed again with goat anti-
mouse antibody conjugated with horseradish peroxidase
(Bio-Rad, Hemel Hempstead, UK) at the dilution 1:1000
for 1 hour at room temperature. Plates were then washed
and the assay was developed as described above.
PBMC proliferation assays
T-cell proliferation assays were conducted as described
previously, [21] using freshly isolated peripheral blood
mononuclear cells (PBMC) from PI, O. volvulus-infected
(INF), and "endemic controls" (i.e., ethnically identical
individuals living in a nearby area where no O. volvulus
transmission has occurred) individuals. Briefly, PBMC
were isolated by centrifugation on lymphocyte separation
medium (Organ on Technical, Durham, NC, USA). The
cells were washed and plated onto 96-well flat-bottomed
tissue culture plates (Corning, Cambridge, MA, USA) at a
concentration of 1 × 106 cells/ml in a volume of 200 µl of
RPMI 1640 (Bio Whittaker, Walkersville, MD, USA) sup-
plemented with 10% human AB serum (Bio Whittaker
Walkersville, MD, USA), 0.08 mg/ml gentamycin (Life
Technology Gibco BRL, Gaithersburg, MD, USA), and 2
mM L-glutamine (Biofluids, Rockville, MD, USA). The
Figure 3
Schematic representation of filarial chitinase gene and the position of recombinant Ov-CHI-1 used in our studiesFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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Figure 4
ELISA analysis of the IgG response to recombinant Ov-CHI-1 5' or 3' antigen in human onchocerciasis. Figure 4A: Comparison 
of the response in the sera of infected (INF) and putatively immune (PI) individuals. Figure 4B: The relationship of response to 
5' antigen and 3' antigen for individual sera. The line of liner regression is shown for data sets in which there is a statistically sig-
nificant correlation between responses to the two antigens (determined by Spearman's Rank Correlation Coefficient).Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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Figure 5
Human cellular immune responses to Ov-CHI-1. PBMC were isolated from individuals were stimulated with recombinant Ov-
CHI-1 proteins. The results are expressed in stimulation indices. Figure 5A: the response to the full-length antigen. Figure 5B: 
the response to 3' antigen of Ov-CHI-1. * P = < 0.05 vs. controls ** P = < 0.01 vs. controlsFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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PBMC were stimulated with purified recombinant O.
voluvus full length chitinase protein and the C-terminal
protein at 10 µg/ml. Appropriate positive and negative
control cultures were also included. All stimulations were
done in triplicate. The plates were incubated at 37°C and
5% CO2 for 5 days, pulsed with 1 µci per well with tritiat-
ed thymidine (DuPont, Boston, USA) for 16 h, and then
harvested onto filter mats for subsequent scintillation
counting. Results were expressed as a geometric mean of
stimulation indexes.
Statistical analysis
Non-parametric statistical analysis was performed using a
Mann Whitney U test, for a groups comparison, Spearman
Rank analysis was used for testing for correlations.
Results and discussions
Serological responses in human onchocerciasis
Antibody responses to Ov-CHI-1 were measured in indi-
viduals from onchocerciasis endemic foci, alongside con-
trols from the United Kingdom (Figure 1A). Optical
densities for samples that exceeded the mean for UK sera
plus 3 standard deviations (OD = 0.185) were taken to be
antibody positive. Responses from the Ecuadorian indi-
viduals were generally weak, with only 22% showing lev-
els of specific IgG above the threshold for positive with a
mean OD of 0.155. Amongst the individuals from Africa,
the proportion of those responding was higher at 62% for
Cameroon, (mean OD = 0.260), 60% for Togo, (mean
OD = 0.241) and 42% for Nigeria, (mean OD = 0.205).
The geometric mean OD from each area showed a signifi-
cant difference when compared with that from UK control
group (P < 0.05). The differences in responses between en-
demic foci from West Africa and Ecuador also showed sta-
tistical significance (P < 0.05, Mann-Whitney U test). This
difference in the levels of responsiveness measured in Lat-
in America and Africa may reflect the difference in inten-
sity of transmission found between the two continents.
Indeed, this difference in antibody production between
Ecuadorians and Africans has been previously observed
with other O. volvulus antigens, such as in responses to
the muscle isoform of tropomyosin, Ov-TMY-1 [22]. The
significantly higher levels of antibodies against Ov-CHI-1
observed to be present in individuals from endemic areas
than in the controls suggested that the immunity to this
antigen is acquired by frequent exposure to infective-stage
larvae. Ov-CHI-1 is a relatively abundant molecule with
strong immunogenicity that could induce a lasting immu-
nogenic response.
Analysis of Ov-CHI-1 antibody levels found in infected
(INF) and putatively immune (PI) individuals within the
four endemic foci was carried out (Figure 1B). Data from
the endemic foci was divided into two groups according to
EMCF criteria. Antibody responses to this antigen appear
to be remarkably persistent following infection, both INF
and PI groups showed high levels although the antibody
levels observed in the INF and PI groups were not signifi-
cantly different from each other. Similar findings have
also been reported in the investigation using recombinant
Ov-DLC (cytoplasmic dynein light chain) and Ov-NIF-1
(A neutrophil inhibition factor) [23]. All these findings
indicated that the acquired concomitant immunity seems
to be present in the four endemic areas, which might have
contributed to the deduction of the differences between PI
and INF groups [24]. Furthermore, some Sowda individu-
als were included in the defined population who enrolled
in our studies, (Sowda individuals have high levels of skin
and lymphatic pathology but low or undetectable levels of
microfilariae), which may affect the infectivity data if the
grouping criteria was based on the numbers of microfilar-
iae. Comparing antibody responses to Ov-CHI-1 with an-
tibody responses to other molecules of O. volvulus [[25],
Y.Wu et al., unpublished data] in the same populations,
we found that Ov-CHI-1 is the only antigen, as yet, iden-
tified and measured in our laboratory that links elevated
marginally antibody levels with putative immunity.
The human antibody response to Ov-CHI-1 is dominated
by IgG3 isotype and to a lesser extent by the IgG1 subclass
(Figure 2), the difference in levels between the two being
significant (P < 0.01). IgG3 has been proposed to be in-
volved in protective mechanisms against filarial parasites
on the basis of its powerful ability to fix complement [26].
IgG3 has also been associated with mediating the target-
ing of antibody-dependent cell cytotoxicity (ADCC) by
binding the Fcγ receptors of neutrophils, eosinophils and
mononuclear cells [27]. A specific IgG3 to a 20 KDa anti-
gen of O. volvulus has been found to predominate in ami-
crofilaraemic or putative immune individuals [28]. Boyer
et al., suggested that IgG3 antibodies were involved in im-
munity to infection / re-infection and the control of mi-
crofilarial densities [29]. It is also notable that eosinophils
have been implicated in the destruction of O. volvulus L3
larvae in a mouse model [30]. A contribution to elevated
IgG3 levels could also be made by the carbohydrate
epitopes in the induction of anti-Ov-CHI-1. In a study car-
ried out by Mohanty et al., significantly elevated levels of
IgG3 and IgG2 antibodies against filarial carbohydrate an-
tigens were detected in PI individuals when compared
with INF individuals. This suggests a potential role of car-
bohydrate antigens in the induction of protective immu-
nity in human filariasis [31]. In our study, although high
IgG3 levels coincided in some cases with the presence of
microfilaremia, (Figure 2B), it is still notable that the
highest levels of IgG3 were seen to be present in individu-
als free of microfilariae. In our data, IgG3 against full
length Ov-CHI-1 shows neither age nor gender correlation
(data not shown). Furthermore, there was no significant
correlation of IgG1 and IgG3 levels (Figure 2C.) It is likelyFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
Page 9 of 14
(page number not for citation purposes)
that induction of IgG3 is dependant on a property of the
antigen itself. Further studies employing large numbers of
individuals would help to ascertain this.
Studies of bacterial and yeast chitinase [32,33] indicate
that the primary chitinase gene structure possesses four
domains. A signal peptide; conserved catalytic domain
present at the n-terminus; a serine/threonine-rich region
located towards the C-terminal and a region which is con-
siderably degenerated amongst filarial chitinases which
adjoins the extreme C-terminal chitin binding domain.
The location of our 5' and 3' Ov-CHI-1 protein is shown
in Figure 3. Published mapping of the MF1 epitope of the
microfilarial chitinase of B. malayi, a chitinase which
shares 72% homology with Ov-CHI-1 at the amino acid
level, has identified the most reactive region against mon-
oclonal antibody MF1 to be located at the carboxy termi-
nus of the gene [19]. The reactive region of the B. malayi
microfilarial chitinase has a high PEST (proline, glutamic
acid, serine, threonine) score in the serine/threonine-rich
region that was suggested to be the calcium-binding re-
gion responsible for activating MF1 in B. malayi micro-
filariae, [34] although this epitope may not be shared with
Ov-CHI-1. We measured the serological activity of patient
sera against 5' and 3' chitinase separately, to ascertain
where the epitopes recognised by human immune system
Figure 6
Analysis of IgG responses to Ov-CHI-1 categorized by age for individual individuals from four endemic regions. Figure 6A: 
Nigeria, Figure 6B: Ecuador, Figure 6C: Togo, Figure 6D: Cameroon.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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against 5' and 3' chitinase are localized. This was done to
ascertain the location of the epitopes recognised by hu-
man sera and to demonstrate which of these epitopes con-
tributed to protection from infection as measured by
microfilarial counts and nodule numbers present. To this
end, we analysed the IgG level against 5' or 3' antigen
separately, dividing them into PI and INF groups, as
shown in Figure 4A. There was no difference found in lev-
els of the IgG to 5' protein between PI and INF individu-
als, whilst IgG against the 3' Ov-CHI-1 was found to be
significantly increased in the PI individuals compared to
the INF individuals (P < 0.05). Panels of sera were also an-
alysed by ELISA against the recombinant 5' and 3' proteins
in parallel (Figure 4B). Levels of antibody to one antigen
were plotted against levels to the other for all individual
serum samples. Interestingly, a significant, positive corre-
lation was observed in the sera tested, (Spearman Rank
Correlation coefficient r = 0.5389, P < 0.001). This result
indicates that individuals responded equally to 5' and 3'
chitinase and the C-terminal and N-terminal proteins are
closely related in terms of provoking humoral immune
response.
Figure 7
Analysis of IgG responses of human onchocerciasis to Ov-CHI-1 categorized by gender and comparison of responses in the 
sera of infected (INF) and putatively immune (PI) individuals from four endemic foci.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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To investigate whether the T cell responses to Ov-CHI-1
were also involved in the processes of infection or immu-
nity in human populations, we employed a T cell prolifer-
ation assay. Freshly isolated PBMCs from individuals
whose immune status had been previously characterised
[35,36] were used to measure the cellular immune re-
sponses either to the full length or to the C-terminal re-
combinant proteins ofOv-CHI-1, (Figure 5). Stimulation
of PBMCs with the pokeweed mitogen as a control (data
not shown) indicated that cells from all individuals in our
experiments were in a valid condition. Results of the as-
says showed there was a statistically significant difference
between controls (ethnically identical individuals living
in a nearby area where no O. volvulus transmission has oc-
curred) and INF and PI individuals (P = < 0.05). PBMCs
from INF individuals had significantly greater prolifera-
tive responses to Ov-CHI-1 antigens than PBMCs from PI
individuals (P = < 0.05). There seems to be a distinction
between humoral and cellular responses in PI and INF in-
dividuals because PI individuals have higher antibody lev-
els to Ov-CHI-1 than INF individuals, whilst T cell
responsiveness of INF individuals was significantly higher
than that of the PI individuals. The presence of segrega-
tion of humoral and cellular immune responses among PI
Figure 8
Analysis of IgG responses to Ov-CHI-1 plotted against microfilarial skin densities for individual individuals from four endemic 
regions. Figure 8A: Nigeria, Figure 8B Ecuador, Figure 8C Togo, Figure 8D. Cameroon. The line of linear regression is shown 
on each graph.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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Figure 9
Analysis of IgG responses to Ov-CHI-1 with respect to skin nodule number for individual subject from four endemic regions. 
Figure 9A: Cameroon, Figure 9B: Ecuador, Figure 9C: Nigeria.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/6
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and INF individuals indicates that it is possible that anti-
bodies to Ov-CHI-1 could in some part mediate protec-
tion of the human from filarial infection. This
phenomena could be caused by retention of memory B
cells and high-affinity antibodies generated during the
course on infection, the effectiveness of the antibodies
produced improving steadily, so that it could provide
long-term immunity to re-infection. It can also be noticed
from Figure 5 that the cellular responses of human on-
chocerciasis exhibit similar pattern in PI and INF individ-
uals to full-length antigen or 3' antigen. As the full-length
protein has been characterized to be immunologically
similar to 5' protein, we assume that the T-cell epitopes of
Ov-CHI-1 are distributed on both termini of the protein.
Ov-CHI-1 is an antigen capable of enhancing cell-mediat-
ed responses upon exposure to O. volvulus infection,
whether cellular-mediated immunity is involved in pro-
tection against infection cannot be excluded. The results
could also mean that the concomitant immunity of the in-
fected individuals has to deal with these T cell responses.
When the data was analysed regarding measurement of
total IgG versus full-length Ov-CHI-1, the results showed
that there was no significant correlation between antibody
levels when analysed with respect to age (Figure 6), sex
(Figure 7), microfilarial densities (Figure 8) or nodule
numbers (Figure 9) in any four endemic foci examined.
The mean antibody titre in PI female individuals was
found to be lower than that of INF female individuals,
whilst in PI male individuals, it was relatively higher than
that of INF male individuals (Figure 7). The results in Fig-
ure 8, demonstrate that the most intense IgG responses to
Ov-CHI-1 were positively correlated with the microfilarial
load of the skin in three of the four foci, excepting Togo.
This could be interpreted as the antibody to Ov-CHI-1
having little effect on reduction of microfilarial density; it
could also imply that it also has little effect on the adult
worms. Ov-CHI-1 is a L3- stage specific antigen; it initiates
synthesis in the late L2-stage of development, reaching its
peak period of production when the third stage larvae are
well developed. It is a secreted antigen, secretion being in-
itiated on transmission from intermediate host to the hu-
man body. The expression of this larval specific chitinase
is a transient process with a definite start and cessation.
Considering these properties, we can assume that the im-
munity induced by Ov-CHI-1 would be limited to a short
period following infection. In endemic areas where the
transmission is very high, frequent exposure to Ov-CHI-1
is likely.
This study reports the immune responses of human on-
chocerciasis patients to Ov-CHI-1 in endemic areas and
has analysed the immunity generated against the larvae of
O. volvulus. Although our results revealed that the natural
infection of O. volvulus strongly provoked both humoral
and cellular immune responses in individuals from en-
demic foci, there is insufficient evidence to support the
use of OV-CHI-1 as a vaccine candidate against Onchocer-
ciasis. Possibly, Ov-L3-CHI could be a molecule present in
the developing infective stage larvae and employed as a
target of prophylactic treatment.
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